Published: Thursday, March 28, 2019
The American Herbal Products Association (AHPA) has adopted a new Guidance Policy for dietary supplement and food products that contain hemp and hemp-derived cannabidiol (CBD) to help ensure the industry complies with existing regulations.
The guidance policy was developed to encourage industry to be mindful of the federal regulations that apply to these product categories, notwithstanding FDA’s ongoing review of the status of CBD and potential pathways for lawful addition of CBD to food and dietary supplements.
"FDA’s current position on the lawful status of CBD shouldn't be misinterpreted to mean that FDA does not regulate supplement or food products that contain hemp or CBD," said AHPA President Michael McGuffin. "Hemp and CBD companies should maintain compliance with established regulations for dietary supplement and food products to ensure quality and safety."
The policy recommends that any manufacturer, labeler, packer, holder or marketer of dietary supplements or foods that contain hemp or CBD comply with the following federal regulations:
AHPA develops guidance policies to promote responsible commerce in herbal supplements by addressing a variety of labeling and manufacturing issues. These policies reflect the consensus of AHPA members and Board of Trustees. AHPA encourages its members and non-member companies to adopt these policies to establish consistent and informed trade practices.
2022 Annual Fund Sponsors
AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.